Voltar
Artigo Revisado por pares
BIBTEX RIS

A phase I study of vistusertib (dual mTORC1/2 inhibitor) in patients with previously treated glioblastoma multiforme: a CCTG study

2019; Springer Science+Business Media; Volume: 38; Issue: 4 Linguagem: Inglês

10.1007/s10637-019-00875-4

ISSN

1573-0646

Autores

Sarah Lapointe, Warren Mason, Mary MacNeil, Craig Harlos, Roger Y. Tsang, Joana Sederias, H. Artee Luchman, Samuel Weiss, John P. Rossiter, Dongsheng Tu, Lesley Seymour, Martin Smoragiewicz,

Tópico(s)

Cancer, Hypoxia, and Metabolism

Referência(s)